NCT03661268

Brief Summary

Fluid challenge is often carried out in septic shock patients. Its responsiveness usually requires invasive monitoring. The pulmonary artery catheter(PAC) is the most effective means of monitoring.To use non-invasive methods is very tempting. Investigators hypothesize that venous-to-arterial carbon dioxide difference,venous-to-arterial carbon oxygen difference, central venous-arterial carbon dioxide to arterial-venous oxygen content ratio and Central Venous SO2 variations provides feasible estimation on fluid responsiveness in septic shock patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
24 days until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

January 28, 2021

Status Verified

January 1, 2021

Enrollment Period

2.4 years

First QC Date

September 2, 2018

Last Update Submit

January 27, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • cardiac index change

    Fluid responsiveness: increase in CI of at least 10% after fluid challenge ;Fluid nonresponsiveness:no increase or increase in CI less than 10%.

    Immediately after fluid challenge

Study Arms (1)

Septic shock

EXPERIMENTAL

Patients (at least 18 years of age, no more than 75 years old) with refractory hypotension secondary to sepsis who, at the discretion of treating physicians, required fluid challenge in the presence of pulmonary artery catheter. Refractory hypotension was defined as need of vasopressors to maintain systolic blood pressure (SBP) no less than 90 mmHg despite adequate fluid resuscitation.

Other: fluid chanllenge

Interventions

A bag of 500ml of normal saline is infused within 15 minutes using a bag pressurized to 300 mmHg.

Septic shock

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • more than 18 years old; less than 75 years old ICU patients
  • Septic shock
  • Monitored with pulmonary artery catheter (Swan-Ganz catheter)
  • The decision of fluid challenge made by the treating physician

You may not qualify if:

  • Evidence of fluid overload
  • Pregnancy
  • Recently participated in other studies
  • Severe heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ICU of Chengdu Fifth People's Hospital

Chengdu, Sichuan, 611130, China

RECRUITING

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • wang ping, MD

    Chengdu Fifth People's Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A bag of 500ml of normal saline is infused within 15 minutes using a bag pressurized to 300 mmHg. All other treatments, including maintenance fluids, dose of vasoactive agents and ventilator settings, remain unchanged during the study period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2018

First Posted

September 7, 2018

Study Start

October 1, 2018

Primary Completion

February 28, 2021

Study Completion

September 30, 2021

Last Updated

January 28, 2021

Record last verified: 2021-01

Locations